{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['A mixture of palladium (II) acetate (79 mg, 0.35 mmol), triphenylphosphine (185 mg, 0.7 mmol) and triethylamine (5 ml), (dried over calcium hydroxide) in dry DMF (80 ml) was maintained at 70° C. with stirring until an intense red color appeared. Compound 19 (2.36 gm, 6.95 mmol) and vinyl acetate (30 ml, 330 mmol) were then added, and the reaction was allowed to proceed at 70° C. for 6 h with stirring. The solvent was removed in vacuo and the residue obtained was extracted with water (2×50 ml). The water layer was washed with dichloromethane, evaporated in vacuo, and the residue obtained was purified by elution from a silica gel column using ethyl acetate-methanol (95:5, v/v) as eluent to give 20 as a viscous oil (800 mg, 48%).',\n",
       " 'In like manner to the preparation of N4-(3,4-ethylenedioxyphenyl)-5-fluoro-N2-[3-(N-methylamino)carbonylmethyleneoxyphenyl]-2,4-pyrimidinediamine, N4-(3,4-ethylenedioxyphenyl)-5-fluoro-N2-(2-methoxycarbonylbenzofuran-5-yl)-2,4-pyrimidinediamine and 2,3-dihydroxypropylamine gave N2-[2-(N-2,3-dihydroxypropylamino)carbonylbenzofuran-5-yl]-N4-(3,4-ethylenedioxyphenyl)-5-fluoro-2,4-pyrimidinediamine. 1H NMR (CD3OD): δ 7.86 (d, 1H, J=4.2 Hz), 7.35 (t, 1H, J=1.2 Hz), 7.24 (d, 1H, J=3 Hz), 7.15 (m, 2H), 7.07 (dd, 1H, J=2.1 and 8.7 Hz), 6.78 (d, 1H, J=8.7 Hz), 6.59 (m, 1H), 4.40 9s, 1H), 4.23 (s, 4H), 4.03 (t, 1H, J=5.7 Hz), 3.67 (d, 2H, 3.6 Hz), 3.65 (d, 2H, J=4.2 Hz); 19F NMR (CD3OD): −47578; LCMS: ret. time: 15.72 min.; purity: 99%; MS (m/e): 486 (MH+).',\n",
       " 'To a stirred solution of 2′-methoxyethoxymethoxy-[1,1′;3′,1″]terphenyl-5′-carboxaldehyde (0.836 g, 2.31 mmol) in CH2Cl2 (25 mL) at room temperature was added MCPBA (0.598 g, 3.46 mmol). The reaction mixture was refluxed for 48 h. After concentration, the residue was dissolved in EtOAc (300 mL). The organic layer 15 was washed with sat. aq. NaHCO3 until effervescence ceased followed brine (30 mL) and then dried (Na2SO4). After concentration, the residue was dissolved in THF:MeOH (3:2, 45 mL) followed by the dropwise addition of 1 N KOH (11.6 mL, 11.6 mmol). The reaction mixture was stirred at room temperature for 1.5 h and then concentrated. The residue was diluted with H2O (30 mL) and then acidified to pH 4 with 1 N HCl followed by extraction with EtOAc (300 mL). This organic layer was washed with brine (30 mL) and then dried (MgSO4). After concentration, the residue was purified by the Biotage Flash 40 apparatus (5 to 15% acetone/hexane gradient) to afford the product (0.490 g, 61%) as a solid; 1H NMR (CDCl3) δ 2.73-2.86 (m, 2H), 2.90-2.98 (m, 2H), 3.17 (s, 3H), 4.35 (s, 2H), 4.67 (s, 1H), 6.82 (s, 2H), 7.27-7.47 (m, 6H), 7.57 (d, J=9.3 Hz, 4H); mass spectrum [(+) ESI], m/z 373 (M+Na)+.',\n",
       " 'To a solution of 4,5-difluoro-benzene-1,2-diamine (2.0 g, 6.94 mmol; CAS Reg. No. 76179-40-3) in o-xylene (25 ml) was added 4-chloro-2-nitro-benzoic acid (2.78 g, 6.94 mmol; CAS Reg. No. 6280-88-2) and titanium tetraethoxide (2.9 ml, 6.94 mmol) at 25° C., and the reaction mixture was allowed to stir at reflux temperature for 14 h. After the completion of reaction, solvents were evaporated under reduced pressure. The residue was purified by column chromatography over silica gel (18-20% ethyl acetate/n-hexane) to afford the desired compound as a yellow powder (15%). MS (Turbo Spray): m/z=310.2 (M+H).',\n",
       " 'The title compound was prepared from 4-iodoacetophenone and 3-(trifluoromethyl)-4,5,6,7-tetrahydro-1H-indazole using a similar procedure to that described for Example 7.']"
      ]
     },
     "execution_count": 8,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "import pandas as pd\n",
    "import joblib\n",
    "import time\n",
    "\n",
    "para_list = joblib.load(\"1000_test_para2compound.pkl\")\n",
    "para_list[:5]"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Zero-shot"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {},
   "outputs": [],
   "source": [
    "message_list = []"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 29,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "500"
      ]
     },
     "execution_count": 29,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(message_list)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 28,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "=====================================================================================================\n",
      "第480条: \n",
      "\n",
      "In a manner similar to that described for Examples 1B-C, the title compound was prepared from 2-[3-(4-methanesulfonyl-phenylcarbamoyl)-2,5-dimethyl-pyrrol-1-yl]-benzoic acid and ammonia. 1H-NMR (DMSO-d6): δ 9.82 (1H, s), 8.08 (2H, d, J=9.1), 7.90 (2H, d, J=9.1), 7.67 (4H, m), 7.39 (1H, s). 7.34 (1H, m), 6.63 (1H, s), 3.23 (3H, s), 2.27 (3H, s), 2.00 (3H, s); MS (ESI): 412 (MH+). C. In a manner similar to that described for Example 21B, the following compounds were prepared from the appropriate amines:\n",
      "title compound | 2-[3-(4-methanesulfonyl-phenylcarbamoyl)-2,5-dimethyl-pyrrol-1-yl]-benzoic acid | ammonia | 1H-NMR | DMSO-d6 | δ 9.82 | 8.08 | 7.90 | 7.67 | 7.39 | 7.34 | 6.63 | 3.23 | 2.27 | 2.00 | MS | ESI | 412 | MH+ | amines\n",
      "{\n",
      "  \"prompt_tokens\": 1348,\n",
      "  \"completion_tokens\": 121,\n",
      "  \"total_tokens\": 1469\n",
      "}\n",
      "=====================================================================================================\n",
      "第481条: \n",
      "\n",
      "A mixture of 8-bromo-6-methyl-[1,2,4]triazolo[1,5-a]pyridin-2-ylamine (1.14 g, 5 mmol), tert-butyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5,6-dihydropyridine-1(2H)-carboxylate (2.39 g, 7.5 mmol), dichloro[1,1′-bis(diphenylphosphino)-ferrocene]palladium(II) dichloromethane adduct (204 mg, 250 μmol) and an aqueous solution of Na2CO3 (2 N, 12.5 mL, 25 mmol) in dioxane (50 mL) was stirred at 110° C. over night. The reaction mixture was diluted with water and extracted twice with EtOAc. The combined organic phases were washed with saturated aqueous sodium chloride solution, dried over sodium sulfate, the solvent was evaporated under reduced pressure and the residue purified by silica gel chromatography using EtOAc as eluent. The title compound was obtained after stirring with diethyl ether, filtration and drying as a light yellow crystalline solid (1.54 g, 93%).\n",
      "8-bromo-6-methyl-[1,2,4]triazolo[1,5-a]pyridin-2-ylamine | tert-butyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5,6-dihydropyridine-1(2H)-carboxylate | dichloro[1,1′-bis(diphenylphosphino)-ferrocene]palladium(II) dichloromethane adduct | Na2CO3 | dioxane | EtOAc | sodium chloride | sodium sulfate | silica gel | EtOAc | title compound | diethyl ether\n",
      "{\n",
      "  \"prompt_tokens\": 1413,\n",
      "  \"completion_tokens\": 153,\n",
      "  \"total_tokens\": 1566\n",
      "}\n",
      "=====================================================================================================\n",
      "第482条: \n",
      "\n",
      "To a stirred solution consisting of 1,5-androstadiene-3β,17β-diol in a mixture of dry ether and glyme is added zinc-copper couple and methylene iodide. This mixture is refluxed for approximately 4 hours, cooled to room temperature, diluted with ether and filtered. The filtrate is washed with aqueous sodium chloride, water and dried over anhydrous magnesium sulfate. The ether is removed under reduced pressure and the residue is crystallized from an acetone-hexane solution to yield 1β,2β-methylene-5-androstene-3β,17β-diol.\n",
      "1,5-androstadiene-3β,17β-diol | dry ether | glyme | zinc-copper couple | methylene iodide | aqueous sodium chloride | water | anhydrous magnesium sulfate | acetone-hexane | 1β,2β-methylene-5-androstene-3β,17β-diol\n",
      "{\n",
      "  \"prompt_tokens\": 1256,\n",
      "  \"completion_tokens\": 73,\n",
      "  \"total_tokens\": 1329\n",
      "}\n",
      "=====================================================================================================\n",
      "第483条: \n",
      "\n",
      "5-bromo-N-methoxy-N-methylpyrimidine-4-carboxamide (2.45 g, 10 mmol) was dissolved in 50 mL of THF and cooled down to −10° C. DIBAL (1.0 M in toluene, 15 mL, and 15 mmol) was added slowly to keep internal temperature at −10° C. After addition, the reaction was quenched with iPrOH and 1N HCl. The mixture was partitioned between EtOAc and brine. The organic layer was separated, dried over MgSO4, filtered and concentrated to afford 1.19 g of the title compound. MS (m/z): 187.2 [M+H]+.\n",
      "5-bromo-N-methoxy-N-methylpyrimidine-4-carboxamide | THF | DIBAL | toluene | iPrOH | HCl | EtOAc | brine | MgSO4\n",
      "{\n",
      "  \"prompt_tokens\": 1282,\n",
      "  \"completion_tokens\": 47,\n",
      "  \"total_tokens\": 1329\n",
      "}\n",
      "=====================================================================================================\n",
      "第484条: \n",
      "\n",
      "A mixture of crude 3-(azidomethyl)-2,6-dimethyl-5-(prop-1-en-2-yl)pyridine and 10.2 mg of 10% Pd/C in 6 mL of MeOH was stirred at r.t. under H2 balloon. After 3 h the mixture was filtered through Celite and concentrated to provide (2,6-dimethyl-5-(prop-1-en-2-yl)pyridin-3-yl)methanamine.\n",
      "(2,6-dimethyl-5-(prop-1-en-2-yl)pyridin-3-yl)methanamine | crude 3-(azidomethyl)-2,6-dimethyl-5-(prop-1-en-2-yl)pyridine | Pd/C | MeOH | Celite | H2\n",
      "{\n",
      "  \"prompt_tokens\": 1234,\n",
      "  \"completion_tokens\": 74,\n",
      "  \"total_tokens\": 1308\n",
      "}\n",
      "=====================================================================================================\n",
      "第485条: \n",
      "\n",
      "A solution of 2,4,6-trimethoxystyryl-3-(3,5-dinitrobenzamido)-4-methoxy-benzylsulfone (example 5) (1.3mmol) in acetone water (10:5) was heated to 50° C. After 30 min, sodiumhydrosulfite (Na2S2O4) (26.3 mmol) was added slowly, and the mixture was heated at reflux (50° C., 1 h.), cooled to room temperature and water was added. The product was rinsed with NaHCO3, and then isolated by extraction with ethyl acetate. The organic layer was dried over anhydrous Na2SO4. The solvent was removed under reduced pressure and the crude product was recrystallized from 2-propanol to yield pure (E)-2,4,6-trimethoxystyryl-3-(3,5,diaminobenzamido)-4-methoxy-benzylsulfone. m.p. 208-210° C. NMR (DMSO-d6) 8 3.76(s, 3H), 3.80(s, 6H), 3.82(s, 3H), 4.4(s, 2H), 5.9(s, 1H), 6.2(s, 2H), 7.05-8.26(m, aromatic), 8.85(s, 1H).\n",
      "2,4,6-trimethoxystyryl-3-(3,5-dinitrobenzamido)-4-methoxy-benzylsulfone | acetone water | sodium hydrosulfite | NaHCO3 | ethyl acetate | anhydrous Na2SO4 | 2-propanol | (E)-2,4,6-trimethoxystyryl-3-(3,5,diaminobenzamido)-4-methoxy-benzylsulfone\n",
      "{\n",
      "  \"prompt_tokens\": 1456,\n",
      "  \"completion_tokens\": 114,\n",
      "  \"total_tokens\": 1570\n",
      "}\n",
      "=====================================================================================================\n",
      "第486条: \n",
      "\n",
      "To a solution of 3-Isopropylamino-5-phenyl-thiophene-2-carboxylic acid methyl ester (136 mg, 0.50 mmol) in 1,2-dichloroethane (1.0 ml) was added (1R, 2S, 4R)-2-Acetoxy-4-methyl-cyclohexanecarboxylic acid chloride (119 mg, 0.54 mmol) dissolved in 1,2-dichloroethane (0.6 ml) followed by PPh3 (136 mg, 0.52 mmol). The resulting solution was stirred for 20 h at 90° C. and then cooled to room temperature. It was then diluted with ethyl acetate (10 ml) and a solution of saturated NaHCO3 (10 ml). The aqueous phase was separated and washed with ethyl acetate (2×10 ml) and the combined organic layers were dried (Na2SO4), filtered and concentrated. The residue was purified by flash chromatography (0% to 25% EtOAc/Hexane) to obtain 110 mg (45%) of (1R, 2S, 4R)-3-[Isopropyl-(2-Acetoxy-4-methyl-cyclohexanecarbonyl) -amino]-5-phenyl-thiophene-2-carboxylic acid methyl ester. NMR 1H (CDCl3, 400 MHz): 1.5:1.0 mixture of rotamers 7,73-7,70 ppm (m, 2H, Haro); 7,69-7,63 ppm (m, 1H, Haro); 7,51-7,41 ppm (m, 4H, Haro); 7,13 ppm (s, 0.6H, Haro, major rotamer); 5,79 ppm (s, 0.4H, minor rotamer); 5,21 ppm (s, 0.6H, major rotamer); 4,95-4,88 ppm (m, 1H); 3,88 ppm (s, 1.8H, major rotamer); 3,87 ppm (s, 1.2H, minor rotamer); 2,40-2,36 ppm (m, 0.6H, major rotamer); 2.11 ppm (s, 3H); 1,78-0,77 ppm (m, 16H).\n",
      "3-Isopropylamino-5-phenyl-thiophene-2-carboxylic acid methyl ester | 1,2-dichloroethane | (1R, 2S, 4R)-2-Acetoxy-4-methyl-cyclohexanecarboxylic acid chloride | PPh3 | ethyl acetate | saturated NaHCO3 | Na2SO4 | EtOAc/Hexane | (1R, 2S, 4R)-3-[Isopropyl-(2-Acetoxy-4-methyl-cyclohexanecarbonyl) -amino]-5-phenyl-thiophene-2-carboxylic acid methyl ester\n",
      "{\n",
      "  \"prompt_tokens\": 1683,\n",
      "  \"completion_tokens\": 160,\n",
      "  \"total_tokens\": 1843\n",
      "}\n",
      "=====================================================================================================\n",
      "第487条: \n",
      "\n",
      "2,6-Dinitro-1-(2-phenylchroman-6-yloxy)-4-trifluoromethylbenzene (0.198 g; 0.43 mmol) was reduced to corresponding diamino compound as described for 2-(2-phenylchroman-6-yloxy)-aniline in Example 29 except that 25 ml of glacial acetic acid and 1.525 g of metallic zinc powder were used. Product was purified by column chromatography (100% CH2Cl2 as the eluant). 1H-NMR (400 MHz; d6-DMSO): δ 7.45-7.28 (m, 5H), 6.76 (d, 1H, J=8.8 Hz), 6.65 (dd, 1H, J=8.7 Hz, J=3.0 Hz), 6.62 (d, 1H, J=2.8 Hz), 5.04 (dd, 1H, J=10.0 Hz, J=2.1 Hz), 4.98 (s, 4H), 2.98-2.86 (m, 1H), 2.70-2.60 (m, 1H), 2.18-2.09 (m, 1H), 2.00-1.88 (m, 1H).\n",
      "2,6-Dinitro-1-(2-phenylchroman-6-yloxy)-4-trifluoromethylbenzene | 2-(2-phenylchroman-6-yloxy)-aniline | CH2Cl2 | 1H-NMR | d6-DMSO\n",
      "{\n",
      "  \"prompt_tokens\": 1430,\n",
      "  \"completion_tokens\": 66,\n",
      "  \"total_tokens\": 1496\n",
      "}\n",
      "=====================================================================================================\n",
      "第488条: \n",
      "\n",
      "A mixture of Example 4e (0.05 g, 0.088 mmol) and propan-1-amine (1 mL, 12.16 mmol) in methanol (0.5 mL) in a sealed tube was heated by microwave at 120° C. for 2 hours, cooled and concentrated to afford the title compound (0.05 g, 98%). The product was used without purification.\n",
      "Example 4e | propan-1-amine | methanol | title compound\n",
      "{\n",
      "  \"prompt_tokens\": 1214,\n",
      "  \"completion_tokens\": 17,\n",
      "  \"total_tokens\": 1231\n",
      "}\n",
      "=====================================================================================================\n",
      "第489条: \n",
      "\n",
      "To a solution of 2,2,2-trifluoro-N-(trans-2-phenylcyclopropyl)-N-(piperidin-4-ylmethyl)acetamide (300 mg, 0.919 mmol) in acetonitrile (10 mL) was added potassium carbonate (381 mg, 2.76 mmol) followed by tert-butyl 3-bromopropanoate (211 mg, 1.011 mmol) was heated in a seal tube at 80° C. for 4 hours. The reaction mixture was filtered, and the filtrate evaporated to dryness. The resulting oil was dissolved in 2 ml of EtOH and 2 ml of 1 M NaOH. The reaction mixture was stirred for 20 min. The solution injected on a preperatory HPLC (2 to 10% AcCN: H2O with 0.1% formic acid modifier). The fractions were collected. To each fraction was added 0.1 ml of 6 M HCl, and the fractions were evaporated to dryness. Acid was formed by deprotection of t-butyl during evaporation. 3-(4-(((trans-2-phenylcyclopropyl)amino)methyl)piperidin-1-yl)propanoic acid (140 mg, 0.354 mmol, 38.5% yield) was isolated as yellow oil. 1H NMR (400 MHz, METHANOL-d4) δ 7.29-7.37 (m, 2H), 7.11-7.29 (m, 3H), 3.65 (br. s., 2H), 3.45 (t, J=7.07 Hz, 2H), 3.23 (d, J=5.81 Hz, 2H), 3.11 (br. s., 2H), 3.04 (dt, J=4.01, 7.89 Hz, 1H), 2.90 (t, J=7.07 Hz, 2H), 2.62 (ddd, J=3.54, 6.63, 10.29 Hz, 1H), 2.04-2.29 (m, 3H), 1.70 (dd, 2H), 1.62 (ddd, J=4.42, 6.51, 10.55 Hz, 1H), 1.42 (q, J=6.91 Hz, 1H); LC-MS Rt=0.42 min; MS (ESI): 303.3 [M+H]+.\n",
      "2,2,2-trifluoro-N-(trans-2-phenylcyclopropyl)-N-(piperidin-4-ylmethyl)acetamide | acetonitrile | potassium carbonate | tert-butyl 3-bromopropanoate | EtOH | NaOH | 3-(4-(((trans-2-phenylcyclopropyl)amino)methyl)piperidin-1-yl)propanoic acid | 1H NMR | METHANOL-d4 | LC-MS\n",
      "{\n",
      "  \"prompt_tokens\": 1707,\n",
      "  \"completion_tokens\": 117,\n",
      "  \"total_tokens\": 1824\n",
      "}\n",
      "=====================================================================================================\n",
      "第490条: \n",
      "\n",
      "A solution of 1.27 g (2.43 mmol) of ethyl 3-{3-[3-(5-carboxypentyloxy)-5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-2-naphthyl]-4-methoxyphenyl}acrylate obtained in Example 24(a) dissolved in 35 ml of dichloromethane was introduced into a round-bottomed flask, 505 μl (2.55 mmol) of dicyclohexylamine were added, and the mixture was stirred for 10 minutes. Then 186 μl (2.55 mmol) of thionyl chloride were added dropwise and the mixture was stirred at room temperature for 10 minutes. The reaction medium was evaporated to dryness, the residue obtained was taken up in ethyl ether, the suspension was filtered and the filtrate was evaporated. The residue obtained was dissolved in 15 ml of THF and the solution was introduced dropwise under nitrogen into a three-necked flask containing 20 ml of THF, 405 μl (2.92 mmol) of triethylamine and 160 μl of a 34% aqueous ammonia solution (2.67 mmol). The mixture was stirred at room temperature for 30 minutes, the reaction medium was poured into water, acidified to a pH of 1 with 1N hydrochloric acid and extracted with ethyl ether, and the organic phase was decanted, dried over magnesium sulfate, filtered and evaporated. The residue obtained was purified by chromatography on a silica column eluted with a mixture of heptane and ethyl acetate (80:20). After evaporation of the solvents, 750 mg (60%) of the expected compound were obtained in the form of a white powder having a melting point of 133°-135° C.\n",
      "ethyl 3-{3-[3-(5-carboxypentyloxy)-5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-2-naphthyl]-4-methoxyphenyl}acrylate | Example 24(a) | dichloromethane | dicyclohexylamine | thionyl chloride | ethyl ether | THF | triethylamine | aqueous ammonia solution | water | hydrochloric acid | heptane | ethyl acetate\n",
      "{\n",
      "  \"prompt_tokens\": 1525,\n",
      "  \"completion_tokens\": 112,\n",
      "  \"total_tokens\": 1637\n",
      "}\n",
      "=====================================================================================================\n",
      "第491条: \n",
      "\n",
      "The reaction of 9-fluoro-3,4,5,6-tetrahydro-1H-2,5-ethanoazepino[4,3-b]indole (230 mg, 1.0 mmol; Example 161) and 2-bromo-6-(1H-pyrazol-1-yl)pyridine (336 mg, 1.5 mmol; Maybridge) was performed as described in Example 68 to afford the title compound: 1H NMR (300 MHz, methanol-d4) δ ppm 1.99-2.14 (m, 2H) 2.15-2.30 (m, 2H) 3.09-3.29 (m, 5H) 4.29 (s, 2H) 6.52-6.57 (m, 1H) 6.90 (td, J=9, 3 Hz, 1H) 7.11 (dd, J=9, 3 Hz, 1H) 7.37 (d, J=8 Hz, 1H) 7.43 (dd, J=9, 4 Hz, 1H) 7.80 (s, 1H) 7.97 (d, J=8 Hz, 1H) 8.16 (t, J=8 Hz, 1H) 8.50 (d, J=3 Hz, 1H); MS (DCI/NH3) m/z 374 (M+H)+.\n",
      "9-fluoro-3,4,5,6-tetrahydro-1H-2,5-ethanoazepino[4,3-b]indole | Example 161 | 2-bromo-6-(1H-pyrazol-1-yl)pyridine | Maybridge | title compound\n",
      "{\n",
      "  \"prompt_tokens\": 1467,\n",
      "  \"completion_tokens\": 69,\n",
      "  \"total_tokens\": 1536\n",
      "}\n",
      "=====================================================================================================\n",
      "第492条: \n",
      "\n",
      "Bromo-3-tert-butyl-5-fluorobenzene (323.2 g, 1.4 moles) was dissolved in THF (3.3 L) and cooled −10° C. iPrMgCl (2M solution in THF, 0.5 eq, 350 mL) was added over 20 min, followed by nBuLi (2.5M solution in hexanes, 1.0 eq, 560 mL) over two hours. DMF (4 eq, 450 mL) was added over one hour then stirred for 45 minutes and quenched with 3M HCl (1000 mL). The layers were separated and the aqueous fraction was diluted with water (1 L) and extracted with ethyl acetate (1 L). The organic fractions were combined and washed with water (2×2 L). The organic fraction was concentrated to provide an orange oil (252 g, quant), used directly in the next reaction.\n",
      "Bromo-3-tert-butyl-5-fluorobenzene | THF | iPrMgCl | nBuLi | DMF | HCl | water | ethyl acetate\n",
      "{\n",
      "  \"prompt_tokens\": 1333,\n",
      "  \"completion_tokens\": 43,\n",
      "  \"total_tokens\": 1376\n",
      "}\n",
      "=====================================================================================================\n",
      "第493条: \n",
      "\n",
      "A solution of 0.20 g of 3,5-dichloro-4-(2-aminoethoxy)-1-(3,3-dichloro-2-propenyloxy)benzene and 0.14 g of 4-trifluoromethoxyphenyl isocyanate dissolved in 10 ml of toluene was heated under reflux, while stirring, for 12 hours, and the reaction mixture was then concentrated to give a residue. The residue was subjected to silica gel chromatography, which afforded 0.15 g of 3,5-dichloro-4-(2-(N'-(4-trifluoromethoxyphenyl)ureido)ethoxy)-1-(3,3-dichloro-2-propenyloxy)benzene (46% yield), m.p., 125.4° C.\n",
      "3,5-dichloro-4-(2-aminoethoxy)-1-(3,3-dichloro-2-propenyloxy)benzene | 4-trifluoromethoxyphenyl isocyanate | toluene | silica gel | 3,5-dichloro-4-(2-(N'-(4-trifluoromethoxyphenyl)ureido)ethoxy)-1-(3,3-dichloro-2-propenyloxy)benzene\n",
      "{\n",
      "  \"prompt_tokens\": 1310,\n",
      "  \"completion_tokens\": 111,\n",
      "  \"total_tokens\": 1421\n",
      "}\n",
      "=====================================================================================================\n",
      "第494条: \n",
      "\n",
      "A mixture of 3-(2-(benzyloxy)-5-methylphenyl)-3-phenylpropyl-4-methylbenzenesulfonate of Formula IVa (40 g), isopropylamine (20 ml), and acetonitrile (200 ml) was stirred at 35-40° C. for 12 hours. The reaction mass was distilled completely, and the obtained residue was crystallized from ethyl acetate (280 ml) to give 28 g of the title compound as a white crystalline powder. Melting point: 137-139° C.\n",
      "3-(2-(benzyloxy)-5-methylphenyl)-3-phenylpropyl-4-methylbenzenesulfonate | Formula IVa | isopropylamine | acetonitrile | ethyl acetate | title compound\n",
      "{\n",
      "  \"prompt_tokens\": 1250,\n",
      "  \"completion_tokens\": 54,\n",
      "  \"total_tokens\": 1304\n",
      "}\n",
      "=====================================================================================================\n",
      "第495条: \n",
      "\n",
      "A mixture of 3-hydroxypiperidine (0.6 g, 5.93 mmol), 4-fluorobenzoic acid (0.83 g, 5.93 mmol), HOBT (0.8 g, 5.93 mmol), EDCI.HCl (1.7 g, 8.9 mmol) and dry triethylamine (1.66 mL, 11.86 mmol) in dry dichloromethane (30 mL) was kept under stiffing overnight at ambient temperature, under nitrogen atmosphere. HCl 1N (30 mL) was then added and the phases separated. The organic layer was washed with HCl 1N (30 mL), with NaOH 1N (30 mL×2 times), then with water (30 mL). Evaporation of the organic solvent afforded (4-fluoro-phenyl)-(3-hydroxy-piperidin-1-yl)-methanone as a white oil (0.7 g).\n",
      "(4-fluoro-phenyl)-(3-hydroxy-piperidin-1-yl)-methanone | 3-hydroxypiperidine | 4-fluorobenzoic acid | HOBT | EDCI.HCl | triethylamine | dichloromethane | HCl | NaOH | water\n",
      "{\n",
      "  \"prompt_tokens\": 1341,\n",
      "  \"completion_tokens\": 72,\n",
      "  \"total_tokens\": 1413\n",
      "}\n",
      "=====================================================================================================\n",
      "第496条: \n",
      "\n",
      "This compound was synthesized in a similar manner to Example 37, from methyl 3-{2-[4-(2-bromo-5-fluorophenoxy)piperidin-1-yl]-7-chloro[1,3]thiazolo[4,5-d]pyrimidin-5-yl}propanoate (50 mg, 0.09 mmol) and methanol (2.0 mL). MS (ESI, Q+) m/z 511, 513 [M+1].\n",
      "methyl 3-{2-[4-(2-bromo-5-fluorophenoxy)piperidin-1-yl]-7-chloro[1,3]thiazolo[4,5-d]pyrimidin-5-yl}propanoate | methanol\n",
      "{\n",
      "  \"prompt_tokens\": 1236,\n",
      "  \"completion_tokens\": 63,\n",
      "  \"total_tokens\": 1299\n",
      "}\n",
      "=====================================================================================================\n",
      "第497条: \n",
      "\n",
      "Using standard HATU coupling conditions, 3-chloro-6-furan-2-yl-8-trifluoromethyl-imidazo[1,2-a]pyridine-2-carboxylic acid, and 1-methyl-2-phenyl-piperazine gave (3-chloro-6-furan-2-yl-8-trifluoromethyl-imidazo[1,2-a]pyridin-2-yl)-(4-methyl-3-phenyl-piperazin-1-yl)-methanone (compound 318). 1H NMR (d6-DMSO): δ 2.49 (m, 1H), 2.60 (brs, 3H), 3.37 (m, 2H), 3.72 (m, 2H), 4.57 (m, 2H), 4.78 (d, 2H, J=12 Hz), 6.66 (brs, 1H), 7.33-7.59 (m, 6H), 7.63 (s, 0.5H), 7.86 (s, 0.5H), 8.18 (s, 0.5H), 8.26 (s, 0.5H), 8.65 (s, 0.5H), 8.71 (s, 0.5H); MS (ESI) m/z=489.1 (MH+).\n",
      "Compound 318 | HATU | 3-chloro-6-furan-2-yl-8-trifluoromethyl-imidazo[1,2-a]pyridine-2-carboxylic acid | 1-methyl-2-phenyl-piperazine | d6-DMSO\n",
      "{\n",
      "  \"prompt_tokens\": 1455,\n",
      "  \"completion_tokens\": 67,\n",
      "  \"total_tokens\": 1522\n",
      "}\n",
      "=====================================================================================================\n",
      "第498条: \n",
      "\n",
      "0.391 g of (6-bromoimidazo[1,2-a]pyridin-2-yl)(phenyl)methanone, 0.237 g of phenylboronic acid, 45 mg of tetrakis(triphenylphosphine)palladium, 4 mL of aqueous 2M sodium carbonate solution, 6 mL of acetonitrile and 6 mL of toluene are introduced into a 20 mL microwave tube. The mixture is stirred for 20 minutes in a microwave machine set at 150° C. After cooling, the organic phase is separated out, dried and evaporated. The residue is taken up in a mixture of dichloromethane and pentane. The solid is filtered off and then purified by trituration in methanol to give 0.16 g of phenyl(6-phenylimidazo[1,2-a]pyridin-2-yl)methanone in the form of an off-white solid.\n",
      "Compound 1 | phenylboronic acid | tetrakis(triphenylphosphine)palladium | sodium carbonate solution | acetonitrile | toluene | dichloromethane | pentane | methanol | phenyl(6-phenylimidazo[1,2-a]pyridin-2-yl)methanone\n",
      "{\n",
      "  \"prompt_tokens\": 1335,\n",
      "  \"completion_tokens\": 75,\n",
      "  \"total_tokens\": 1410\n",
      "}\n",
      "=====================================================================================================\n",
      "第499条: \n",
      "\n",
      "tert-Butyl (E)-3-[2-[3-(aminocarbonyl)piperidino]-8-([4-(tert-butyl)-1,3-thiazol-2-yl]aminocarbonyl)-4-oxo-4H-pyrido[1,2-a]pyrimidin-3-yl]-2-propenoate (60.6 mg, 0.10 mmol) was dissolved in 4 N hydrochloric acid in dedioxane (6 ml) and stirred at room temperature for 3 hours. The solvent and the excessive reagents were evaporated, and the residue was subjected to azeotropy with ether. The residue was purified by preparative PLC (chloroform:methanol=10:1, v/v) and lyophilized from dioxane to obtain the title compound (35.8 mg, 65.4%) as orange powder.\n",
      "t-Butyl | (E)-3-[2-[3-(aminocarbonyl)piperidino]-8-([4-(tert-butyl)-1,3-thiazol-2-yl]aminocarbonyl)-4-oxo-4H-pyrido[1,2-a]pyrimidin-3-yl]-2-propenoate | hydrochloric acid | dedioxane | azeotropy | ether | preparative PLC | chloroform | methanol | dioxane | title compound\n",
      "{\n",
      "  \"prompt_tokens\": 1320,\n",
      "  \"completion_tokens\": 114,\n",
      "  \"total_tokens\": 1434\n",
      "}\n"
     ]
    }
   ],
   "source": [
    "import openai\n",
    "import os\n",
    "from tqdm import tqdm\n",
    "\n",
    "# 设置 API key\n",
    "openai.api_key = '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' # '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'\n",
    "\n",
    "\n",
    "for i in range(480, 500):\n",
    "    print(\"=====================================================================================================\")\n",
    "    print(f\"第{i}条: \\n\")\n",
    "\n",
    "    prompt = '''Please just extract all compound names in the paragraph, the compound names should be split in \" | \". If there is no compound name in whole paragraph, please return \"N/A\". \n",
    "    \n",
    "    Example1:\n",
    "    Input: Compound 610 (102 mg, 0.366 mmol) was dissolved in DMF (3 mL), and 3-pyridylacetic acid hydrochloride (635 mg, 3.66 mmol), EDC hydrochloride (702 mg, 3.66 mmol), 1-hydroxybenzotriazole monohydrate (561 mg, 3.66 mmol) and triethylamine (0.510 mL, 3.66 mmol) were added thereto, followed by stirring at 80° C. for 10 hours. The reaction mixture was poured into a saturated aqueous solution of sodium hydrogencarbonate, and the precipitated solid was collected by filtration. The resulting solid was purified through silica gel column chromatography (hexane:ethyl acetate=2:1), followed by recrystallizing from a mixed solvent of ethanol and water to afford the entitled Compound 618 (74.6 mg, 52%) as a white solid.\n",
    "    Output: Compound 610 | DMF | 3-pyridylacetic acid hydrochloride | EDC hydrochloride | 1-hydroxybenzotriazole monohydrate | triethylamine | sodium hydrogencarbonate | silica gel | hexane:ethyl acetate | ethanol | water | Compound 618\n",
    "\n",
    "    Example2:\n",
    "    Input: 6-amino-2-{[(1S)-1-methylbutyl]oxy}-9-[5-(1-piperidinyl)pentyl]-7,9-dihydro-8H-purin-8-one (for example, as prepared for Reference Example 1) (0.384 g, 0.98 mmol) was dissolved in isopropyl alcohol (4.6 mL, 12 vols) and heated to 40° C. Maleic acid (0.114 g, 0.98 mmol) was added. A clear solution was obtained. During cooling to room temperature, precipitation occurred. The slurry was filtered, washing with isopropyl alcohol (5 mL) and dried under reduced pressure at 40° C. to constant weight. 6-amino-2-{[(1S)-1-methylbutyl]oxy}-9-[5-(1-piperidinyl)pentyl]-7,9-dihydro-8H-purin-8-one, maleate salt (0.305 g, 61% th) was obtained as a white solid.\n",
    "    Output: 6-amino-2-{[(1S)-1-methylbutyl]oxy}-9-[5-(1-piperidinyl)pentyl]-7,9-dihydro-8H-purin-8-one | isopropyl alcohol | Maleic acid | 6-amino-2-{[(1S)-1-methylbutyl]oxy}-9-[5-(1-piperidinyl)pentyl]-7,9-dihydro-8H-purin-8-one, maleate salt \n",
    "    \n",
    "    Example3:\n",
    "    Input: Thionyl chloride (2 ml) was added to 3-[2-(4-phenyl-2-thiazolyl)vinyl]benzoic acid (0.45 g, 1.46 mmol), the mixture was stirred with heating under reflux for 30 minutes, and then the reaction solution was concentrated under reduced pressure. Toluene was added to the resulting residue, the mixture was concentrated under reduced pressure and, after repeating this step again, dried in vacuo. The resulting residue was added to a mixture of 2-amino-4-[3-(4-chlorophenylsulfonyl)propyl]phenol hydrochloride (0.50 g, 1.38 mmol), pyridine (3 ml) and dichloromethane (2 ml) with stirred under ice-cooling, followed by 12 hours of reaction at room temperature. The reaction solution was poured into ice and 1 N hydrochloric acid and the solid precipitated was collected by filtration. By washing the collected solid with ethanol, 5'-[3-(4-chlorophenylsulfonyl)propyl]-2'-hydroxy-3-[2-(4-phenyl-2-thiazolyl)vinyl]benzanilide (0.79 g, 1.28 mmol, 93%) was obtained as a solid.\n",
    "    Output: Thionyl chloride | 3-[2-(4-phenyl-2-thiazolyl)vinyl]benzoic acid | Toluene | 2-amino-4-[3-(4-chlorophenylsulfonyl)propyl]phenol hydrochloride | pyridine | dichloromethane | hydrochloric acid | ethanol | 5'-[3-(4-chlorophenylsulfonyl)propyl]-2'-hydroxy-3-[2-(4-phenyl-2-thiazolyl)vinyl]benzanilide\n",
    "    \n",
    "    '''\n",
    "    content = para_list[i]\n",
    "    print(content)\n",
    "\n",
    "    completions = openai.ChatCompletion.create(\n",
    "        model=\"gpt-3.5-turbo\",\n",
    "        messages=[\n",
    "            {\"role\": \"assistant\", \"content\": prompt },\n",
    "            {\"role\": \"user\", \"content\": content }]\n",
    "    )\n",
    "    \n",
    "    # 获取 chatGPT 的回复\n",
    "    message = completions.choices[0].message.content\n",
    "    message_list.append(message)\n",
    "    print(message)\n",
    "\n",
    "    # 获取耗费的tokens数量\n",
    "    usage = completions.usage\n",
    "    print(usage)\n",
    "    \n",
    "    time.sleep(20)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 30,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['500_test_para2compound_3_shots.pkl']"
      ]
     },
     "execution_count": 30,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "import joblib\n",
    "joblib.dump(message_list, \"500_test_para2compound_3_shots.pkl\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['1000_test_para2compound.pkl']"
      ]
     },
     "execution_count": 17,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "import joblib\n",
    "joblib.dump(message_list, \"1000_test_para2compound_zero_shot.pkl\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "import joblib"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.10.11"
  },
  "orig_nbformat": 4
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
